Arra, Antonio, Daniel Coso, and Layla Chagas Guimaraes. “SATB.2 Is a Sensityive for Well Differentiated Neuroendocrine Tumors”. Interamerican Journal of Health Sciences, no. 1 (December 3, 2021). Accessed December 7, 2022. https://ijhsc.com/journal/article/view/4.